Literature DB >> 23653349

p21-activated kinase 1 (PAK1) can promote ERK activation in a kinase-independent manner.

Zhipeng Wang1, Meng Fu, Lifeng Wang, Juanjuan Liu, Yuhua Li, Cord Brakebusch, Qibing Mei.   

Abstract

PAK1 plays an important role in proliferation and tumorigenesis, at least partially by promoting ERK phosphorylation of C-RAF (Ser-338) or MEK1 (Ser-298). We observed how that overexpression of a kinase-dead mutant form of PAK1 increased phosphorylation of MEK1/2 (Ser-217/Ser-221) and ERK (Thr-202/Tyr-204), although phosphorylation of B-RAF (Ser-445) and C-RAF (Ser-338) remained unchanged. Furthermore, increased activation of the PAK1 activator Rac1 induced the formation of a triple complex of Rac1, PAK1, and MEK1 independent of the kinase activity of PAK1. These data suggest that PAK1 can stimulate MEK activity in a kinase-independent manner, probably by serving as a scaffold to facilitate interaction of C-RAF.

Entities:  

Keywords:  ERK; MAP Kinases (MAPKs); MEK; PAK; RAF; Rac1; Scaffold Proteins

Mesh:

Substances:

Year:  2013        PMID: 23653349      PMCID: PMC3707706          DOI: 10.1074/jbc.M112.426023

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Biology of the p21-activated kinases.

Authors:  Gary M Bokoch
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

2.  Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo.

Authors:  Z Wang; E Pedersen; A Basse; T Lefever; K Peyrollier; S Kapoor; Q Mei; R Karlsson; A Chrostek-Grashoff; C Brakebusch
Journal:  Oncogene       Date:  2010-04-12       Impact factor: 9.867

Review 3.  The p21Rac/Cdc42-activated kinases (PAKs).

Authors:  U G Knaus; G M Bokoch
Journal:  Int J Biochem Cell Biol       Date:  1998-08       Impact factor: 5.085

4.  P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.

Authors:  Nhi Huynh; Kevin H Liu; Graham S Baldwin; Hong He
Journal:  Biochim Biophys Acta       Date:  2010-06-01

5.  Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors.

Authors:  Alexander Beeser; Zahara M Jaffer; Clemens Hofmann; Jonathan Chernoff
Journal:  J Biol Chem       Date:  2005-08-29       Impact factor: 5.157

6.  The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338.

Authors:  A J King; H Sun; B Diaz; D Barnard; W Miao; S Bagrodia; M S Marshall
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

Review 7.  Pak protein kinases and their role in cancer.

Authors:  Bettina Dummler; Kazufumi Ohshiro; Rakesh Kumar; Jeffrey Field
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

8.  Erk1/2 MAP kinases are required for epidermal G2/M progression.

Authors:  Phillip A Dumesic; Florence A Scholl; Deborah I Barragan; Paul A Khavari
Journal:  J Cell Biol       Date:  2009-05-04       Impact factor: 10.539

9.  Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase).

Authors:  D M Payne; A J Rossomando; P Martino; A K Erickson; J H Her; J Shabanowitz; D F Hunt; M J Weber; T W Sturgill
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

10.  PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation.

Authors:  Jill K Slack-Davis; Scott T Eblen; Maja Zecevic; Scott A Boerner; Adel Tarcsafalvi; H Bruce Diaz; Mark S Marshall; Michael J Weber; J Thomas Parsons; Andrew D Catling
Journal:  J Cell Biol       Date:  2003-07-21       Impact factor: 10.539

View more
  29 in total

Review 1.  Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics.

Authors:  Bhagwat Prasad; Jashvant D Unadkat
Journal:  AAPS J       Date:  2014-04-22       Impact factor: 4.009

Review 2.  p21-Activated Kinases in Thyroid Cancer.

Authors:  Luis Bautista; Christina M Knippler; Matthew D Ringel
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

Review 3.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

4.  MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition.

Authors:  Christina M Knippler; Motoyasu Saji; Neel Rajan; Kyle Porter; Krista M D La Perle; Matthew D Ringel
Journal:  Endocr Relat Cancer       Date:  2019-08       Impact factor: 5.678

5.  β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.

Authors:  Jun-Song Liu; Xiang-Ming Che; Shuai Chang; Guang-Lin Qiu; Shi-Cai He; Lin Fan; Wei Zhao; Zheng-Liang Zhang; Shu-Feng Wang
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

6.  Involvement of Rac1 signalling pathway in the development and maintenance of acute inflammatory pain induced by bee venom injection.

Authors:  Yan Wang; Yun-Fei Lu; Chun-Li Li; Wei Sun; Zhen Li; Rui-Rui Wang; Ting He; Fan Yang; Yan Yang; Xiao-Liang Wang; Su-Min Guan; Jun Chen
Journal:  Br J Pharmacol       Date:  2016-02-10       Impact factor: 8.739

7.  Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias.

Authors:  Caroline M Gorvin; Morten Frost; Tomas Malinauskas; Treena Cranston; Hannah Boon; Christian Siebold; E Yvonne Jones; Fadil M Hannan; Rajesh V Thakker
Journal:  Hum Mol Genet       Date:  2018-11-01       Impact factor: 6.150

8.  Overexpressed Down Syndrome Cell Adhesion Molecule (DSCAM) Deregulates P21-Activated Kinase (PAK) Activity in an In Vitro Neuronal Model of Down Syndrome: Consequences on Cell Process Formation and Extension.

Authors:  Ramón Pérez-Núñez; Natalia Barraza; Arlek Gonzalez-Jamett; Ana Maria Cárdenas; Jean-Vianney Barnier; Pablo Caviedes
Journal:  Neurotox Res       Date:  2016-03-10       Impact factor: 3.911

9.  IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer.

Authors:  Yinghui Zhang; Lynn Wester; Jichao He; Tamar Geiger; Marja Moerkens; Ram Siddappa; Jean A Helmijr; Mieke M Timmermans; Maxime P Look; Caroline H M van Deurzen; John W M Martens; Chantal Pont; Marjo de Graauw; Erik H J Danen; Els M J J Berns; John H N Meerman; Maurice P H M Jansen; Bob van de Water
Journal:  Oncogene       Date:  2018-01-22       Impact factor: 9.867

10.  Clinicopathological and cellular signature of PAK1 in human bladder cancer.

Authors:  Kai Huang; Gang Chen; Jingfang Luo; Youyuan Zhang; Guoxiong Xu
Journal:  Tumour Biol       Date:  2014-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.